A possible cancer drug target looked safe in mice
Original title: AVIL is dispensable for baseline neurobehavioral and somatosensory function in mice.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in mice.
The short version
Mice stayed healthy without a protein that some brain tumors make too much of.
What was studied. Scientists looked at a protein called advillin, or AVIL. Some low grade gliomas and glioblastomas make too much of it. They bred mice without the Avil gene and also gave mice a new drug that blocks AVIL.
What they found. Mice without Avil behaved like normal mice. They moved, explored, learned, and remembered as usual. Their sense of pain and touch stayed normal, and the nerve structures under the skin looked normal too. The drug that blocks AVIL also caused no harm in the tests used.
What this means, and what it doesn't
What it could mean: AVIL might be a safe thing for future cancer drugs to block. That is helpful early news, because a drug has to be safe before it can help anyone.
What it doesn't mean: This does not mean there is a new treatment. All of this work was done in mice, not people. No one has shown that blocking AVIL shrinks a tumor in a patient. It is not a cure, and it is a long way from the care you get today.
Source: PubMed, October 27, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.